Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg

CCDC 639296: Experimental Crystal Structure Determination

Related Article: J.Becker, R.Frohlich, K.Salorinne, D.Hoppe|2007|Eur.J.Org.Chem.|2007|3337|doi:10.1002/ejoc.200700219

Supplementary Material for: Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves’ Orbitopathy: A Prospective Trial

Objectives: To investigate the predictive factors for changes in the quality of life (GO-QoL) of patients with Graves’ orbitopathy (GO) prior to and after specific treatment. Methods: A prospective follow-up study was conducted at an academic tertiary referral orbital center with a joint thyroid-eye clinic on 100 consecutive patients with GO. Before and after the standard 12-week course of weekly intravenous methylprednisolone (cumulative dose 4.5 g), the GO-QoL questionnaire provided by the European Group on Graves’ Orbitopathy (EUGOGO) was completed. Endocrine and ophthalmic assessments were performed at each visit. Results: All patients were biochemically euthyroid and untreated for GO a…

CCDC 639295: Experimental Crystal Structure Determination

Related Article: J.Becker, R.Frohlich, K.Salorinne, D.Hoppe|2007|Eur.J.Org.Chem.|2007|3337|doi:10.1002/ejoc.200700219

CCDC 639294: Experimental Crystal Structure Determination

Related Article: J.Becker, R.Frohlich, K.Salorinne, D.Hoppe|2007|Eur.J.Org.Chem.|2007|3337|doi:10.1002/ejoc.200700219

CCDC 639293: Experimental Crystal Structure Determination

Related Article: J.Becker, R.Frohlich, K.Salorinne, D.Hoppe|2007|Eur.J.Org.Chem.|2007|3337|doi:10.1002/ejoc.200700219